NovaBay’s NeutroPhase(R) Supports Healing of Chronic Wounds New Patient Case Studies Highlighted at the 2012 Spring Symposium on Advanced Wound Care – SBWire

Emeryville, CA — (SBWIRE) — 04/25/2012 — NovaBay(R) Pharmaceuticals, Inc. (NYSE AMEX:NBY), a biotech company developing novel anti-infective products for the treatment and prevention of microbial infections, today announced its pure hypochlorous acid …